Analytical Data
-
Gene name
UQCR10
- Application
-
Alternative Names
Complex III subunit 9 Complex III subunit X Cytochrome c1 non-heme 7KDA protein Ubiquinol-cytochrome c reductase complex 7.2KDA protein
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UDW1
-
Expression Region
1-63aa
-
Molecular Weight
34.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UQCR10, a component of the mitochondrial respiratory chain, plays a critical role in cellular energy production by participating in the transfer of electrons from ubiquinol to cytochrome c. Its significance is underscored by its involvement in various cellular processes, including apoptosis and reactive oxygen species (ROS) generation. Research into UQCR10 has gained momentum as scientists seek to understand its implications in metabolic disorders, neurodegenerative diseases, and cancer. The recombinant expression of UQCR10 allows for detailed studies of its structure and function, facilitating the exploration of its potential as a therapeutic target. Recent advancements in protein expression techniques have made it feasible to produce UQCR10 in substantial quantities, enabling in vitro assays and structural analyses. Understanding the mechanistic pathways of UQCR10 could provide insights into mitochondrial dysfunction, paving the way for the development of innovative interventions for diseases linked to mitochondrial abnormalities. Additionally, elucidating the functional properties of UQCR10 could enhance our understanding of the broader mitochondrial network and its influence on cellular health, offering perspectives on preventative strategies against mitochondrial-related diseases. Overall, the study of recombinant UQCR10 holds promise for advancing our knowledge of mitochondrial biology and its implications in health and disease.
